Format

Send to

Choose Destination
Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69. doi: 10.1016/j.hoc.2010.11.011.

Cytomegalovirus in hematopoietic stem cell transplant recipients.

Author information

1
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.

Abstract

This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.

Republished from

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center